News

Warnex will distribute Rosetta Genomics' three recently launched miRview™ tests in Canada.

SynCo Bio Partners, a Netherlands based biopharmaceutical contract manufacturer, and Versartis, Inc. today announced a strategic partnership to produce Versartis’ lead drug candidate VRS-859, a novel GLP-1 analog for monthly dosing to treat type 2 diabetes.

EMBL scientists identify a rapid response team that monitors and quickly responds to DNA damage.

It's essential that bureaucrats and activists stop blocking agricultural technologies that can give us more crop for the drop.

"No single study should be taken too seriously until other studies have confirmed the findings."

Only Four per cent of interviewees cited GM foods spontaneously when requested to identify food issues of concern. T

Under the terms of the agreement, DiLab’s instrument for automated blood sampling (ABS), the AccuSampler Micro, will be adapted to accommodate Spark Holland’s recently developed blood collection cartridges for direct processing in its SYMBIOSIS™ system for online solid phase extraction (SPE).

Company’s LibiGel Phase III study clinical data indicates a very low cardiovascular event rate.

Collaborations is focused on highly selective Adenosine A2A Agonists to enhance multiple myeloma treatment.

Researchers at UC San Diego have discovered how a Chinese drug effective in killing parasitic roundworms works.